This work is licensed under a Creative Commons Attribution 4.0 International License.
AS-2 (SEQ ID NO:22 for Patent US 20030186868 A1)
General Information
DRACP ID DRACP02497
Peptide Name AS-2 (SEQ ID NO:22 for Patent US 20030186868 A1)
Sequence RRPKGRAAARREKQRPSDKPRR
Sequence Length 22
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP Cancer targeted peptides Antiangiogenic Antagonists of VEGF165 signaling through
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target VEGF165
Affinity Not available
Mechanism Its mechanism that involves competition for VEGF165 binding at either the VEGFR-2/NP-1 complex or NP-11, without affecting VEGF signaling through other pathways.
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C109H198N50O29
Absent amino acids CFHILMNTVWY
Common amino acids R
Mass 304781
Pl 12.73
Basic residues 11
Acidic residues 2
Hydrophobic residues 3
Net charge 9
Boman Index -15411
Hydrophobicity -267.27
Aliphatic Index 13.64
Half Life
Mammalian: 1.3 hour
Yeast: 3 min
E.coli: 2 min
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 2
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID US 20030186868 A1
Patent Title Anti-angiogenic peptides
Other Iinformation Patent Application; Family: 5s / 5ex; Family Jurisdictions: AU, US, WO; Legal Status: Expired; Application No: 26316202; Filed: Oct 2, 2002; Published: Oct 2, 2003; Earliest Priority: Oct 3, 2001; Granted: May 30, 2006
Other Published ID AU2002340080A1 US7052705B2 WO03029275A2 WO03029275A3
This work is licensed under a Creative Commons Attribution 4.0 International License.